Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuropharmacology

• Publication date

  2015-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuropharm.2014.12.025PMID 25576372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of [11C]yohimbine binding to α2 adrenoceptors in rat brain in vivo

  2015cited by this paper
• The Flinders Sensitive Line Rat Model of Depression—25 Years and Still Producing

  2013cited by this paper
• Effects of Anesthesia and Species on the Uptake or Binding of Radioligands In Vivo in the Göttingen Minipig

  2013cited by this paper
• Gene—Environment Interactions in Major Depressive Disorder

  2013cited by this paper
• Depression: a global public health concern

  2012cited by this paper
• α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy.

  2012cited by this paper
• Amphetamine challenge decreases yohimbine binding to α2 adrenoceptors in Landrace pig brain

  2012cited by this paper
• Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions.

  2011cited by this paper
• Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression

  2010cited by this paper
• Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression.

  2010cited by this paper
• Antidepressant treatment facilitates dopamine release and drug seeking behavior in a genetic animal model of depression

  2009cited by this paper
• Triple Reuptake Inhibitors: The Next Generation of Antidepressants

  2008cited by this paper
• Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression.

  2007cited by this paper
• Detection of α2-Adrenergic Receptors in Brain of Living Pig with 11C-Yohimbine

  2006cited by this paper
• Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine.

  2006cited by this paper
• Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders

  2006cited by this paper
• Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study.

  2006cited by this paper
• The Flinders Sensitive Line rat: a selectively bred putative animal model of depression.

  2005cited by this paper
• Selective breeding for diisopropyl fluorophosphate-sensitivity: Behavioural effects of cholinergic agonists and antagonists

  2004cited by this paper
• Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression.

  2004cited by this paper
• Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims.

  2004cited by this paper
• Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims

  2004cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain

  2003cited by this paper
• Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.

  2003cited by this paper
• Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression.

  2003cited by this paper
• Noradrenaline in mood and anxiety disorders: basic and clinical studies

  2003cited by this paper
• Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of α2A-adrenoceptors

  2002cited by this paper
• The cellular neurobiology of depression

  2001cited by this paper
• Yohimbine: a clinical review.

  2001cited by this paper
• Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review

  2000cited by this paper
• Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.

  2000cited by this paper
• Role of norepinephrine in the pathophysiology and treatment of mood disorders.

  1999cited by this paper
• Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment.

  1999cited by this paper
• The effects of stressful life events on depression.

  1997cited by this paper
• Manipulation of Norepinephrine Metabolism with Yohimbine in the Treatment of Autonomic Failure

  1994cited by this paper
• Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil.

  1994cited by this paper
• Autoradiographic Demonstration of Increased α2‐Adrenoceptor Agonist Binding Sites in the Hippocampus and Frontal Cortex of Depressed Suicide Victims

  1994cited by this paper
• Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects

  1990cited by this paper
• Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.

  1989cited by this paper
• Selective breeding for increased cholinergic function: development of a new animal model of depression.

  1986cited by this paper
• Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.

  1984cited by this paper
• Presnyaptic noradrenergic regulation during depression and antidepressant drug treatment

  1980cited by this paper
• The catecholamine hypothesis of affective disorders: a review of supporting evidence.

  1965cited by this paper

• Neurobiological Mechanisms of Electroconvulsive Therapy: Molecular Perspectives of Brain Stimulation

  2025cites this paper
• An Updated Bio‐Behavioral Profile of the Flinders Sensitive Line Rat: Reviewing the Findings of the Past Decade

  2025cites this paper
• Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential

  2024cites this paper
• Anesthetic Influence on Electroconvulsive Therapy: A Comprehensive Review

  2024cites this paper
• Genetically predisposed and resilient animal models of depression reveal divergent responses to early-life adversity

  2023cites this paper
• Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression.

  2023cites this paper
• Increased depressive-like behaviour of postpartum Flinders sensitive and resistant line rats is reversed by a predictable postpartum stressor.

  2023cites this paper
• PET imaging of animal models with depressive-like phenotypes

  2023cites this paper
• Role of GABAergic system in the comorbidity of pain and depression.

  2023cites this paper
• Sex differences in chronic pain-induced mental disorders: Mechanisms of cerebral circuitry

  2023cites this paper
• Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications

  2022cites this paper
• Hippocampal monoamine changes in the Flinders sensitive line rat: A case for the possible use of selective α2C-AR-antagonists in stress and anxiety disorders in companion animals.

  2021cites this paper
• Molecular Biological Aspects of Depressive Disorders: A Modern View

  2020cites this paper
• The potential anti-depressant properties of dexmedetomidine infusion: a review of mechanistic, preclinical, and clinical evidence

  2020cites this paper
• Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders.

  2019cites this paper
• Alpha2-adrenergic dysregulation in congenic DxH recombinant inbred mice selectively bred for a high fear-sensitized (H-FSS) startle response.

  2019cites this paper
• Dexmedetomidine Alleviates Postpartum Depressive Symptoms following Cesarean Section in Chinese Women: A Randomized Placebo‐Controlled Study

  2019cites this paper
• α2-Adrenoceptor-ir neurons’ density changes after single dose of clonidine and yohimbine administration in the hippocampus of male rat

  2018cites this paper
• Opioid modulation of depression: A focus on imaging studies.

  2018cites this paper
• Molecular mechanism of noradrenaline during the stress-induced major depressive disorder

  2018cites this paper
• Radioligand binding analysis of α2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding

  2017cites this paper
• Syddansk Universitet Radioligand binding analysis of 2 adrenoceptors with [ 11 C ] yohimbine in brain in vivo Extended Inhibition Plot correction for plasma protein binding

  2017cites this paper
• Neonatal domoic acid alters in vivo binding of [11C]yohimbine to α2-adrenoceptors in adult rat brain

  2016cites this paper
• Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress.

  2016cites this paper
• The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect

  2016cites this paper
• How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?

  2015cites this paper